PRESS RELEASE published on 11/05/2025 at 18:19, 6 months 8 days ago SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Christian Mias appointed as CEO of SCHOTT Pharma, succeeding Andreas Reisse. Strategic leadership transition ensured for global pharmaceutical packaging leader Pharmaceutical SCHOTT Pharma CEO Christian Mias Andreas Reisse
BRIEF published on 11/05/2025 at 18:01, 6 months 8 days ago Christian Mias nommé nouveau PDG de SCHOTT Pharma SCHOTT Pharma Nomination Du PDG Changement De Leadership Christian Mias Andreas Reisse
BRIEF published on 11/05/2025 at 18:01, 6 months 8 days ago Christian Mias Appointed as New CEO of SCHOTT Pharma CEO Appointment SCHOTT Pharma Leadership Change Christian Mias Andreas Reisse
PRESS RELEASE published on 11/05/2025 at 17:56, 6 months 8 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO SCHOTT Pharma AG & Co. KGaA appoints Christian Mias as CEO to succeed Andreas Reisse, effective May 1, 2026. Inside information disclosed. Press release via EQS News Inside Information CEO Appointment SCHOTT Pharma EQS News Christian Mias
BRIEF published on 08/12/2025 at 07:05, 9 months 1 day ago SCHOTT Pharma Reports Steady Q3 2025 Results Innovation SCHOTT Pharma High-value Solutions Drug Containment Q3 2025 Results
BRIEF published on 08/12/2025 at 07:05, 9 months 1 day ago SCHOTT Pharma annonce des résultats stables au troisième trimestre 2025 Innovation SCHOTT Pharma Solutions À Haute Valeur Ajoutée Confinement Des Drogues Résultats Du Troisième Trimestre 2025
PRESS RELEASE published on 08/12/2025 at 07:00, 9 months 1 day ago SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
BRIEF published on 08/05/2025 at 10:00, 9 months 8 days ago SCHOTT Pharma's Q3 2025 Highlights and FY 2025 Outlook Revenue Growth EBITDA Margin Financial Outlook Q3 2025 High Value Solutions
BRIEF published on 08/05/2025 at 10:00, 9 months 8 days ago Faits marquants du troisième trimestre 2025 et perspectives pour l'exercice 2025 de SCHOTT Pharma Marge EBITDA Croissance Des Revenus Solutions À Haute Valeur Ajoutée Perspectives Financières T3 2025
BRIEF published on 08/05/2025 at 09:58, 9 months 8 days ago SCHOTT Pharma Updates FY 2025 Revenue and EBITDA Guidance Financial Results Revenue Growth EBITDA Margin SCHOTT Pharma FY 2025 Guidance
Published on 05/13/2026 at 22:15, 15 minutes ago Qué tal Móvil Selects Amdocs connectX to Launch Multi-Aggregator MVNO Platform, Accelerating Time to Market
Published on 05/13/2026 at 22:10, 20 minutes ago Vodafone Ireland Goes Live with Amdocs Network Inventory to Drive Network Automation and Simplification
Published on 05/13/2026 at 22:05, 25 minutes ago Telefónica Móviles Argentina Signs Strategic Multi-Year Agreement with Amdocs to Advance its Operational Excellence
Published on 05/13/2026 at 22:05, 25 minutes ago Norse Gold Announces Results of its Annual and Special Meeting of Shareholders
Published on 05/13/2026 at 22:01, 29 minutes ago Amdocs Limited Reports Second Quarter Fiscal 2026 Results
Published on 05/13/2026 at 20:18, 2 hours 11 minutes ago EQS-Adhoc: Northern Data Group Q1 2026 – Above the Preliminary Ranges Communicated on 8 April 2026
Published on 05/13/2026 at 19:28, 3 hours 1 minute ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/13/2026 at 19:14, 3 hours 15 minutes ago EQS-Adhoc: Oldenburgische Landesbank AG: Oldenburgische Landesbank AG intends to call its Additional Tier 1 bond
Published on 05/13/2026 at 18:15, 4 hours 15 minutes ago Africa Energy Forum 2026: Building Africa's Industrialised Future
Published on 05/13/2026 at 18:02, 4 hours 27 minutes ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 4 hours 30 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 4 hours 45 minutes ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
